Research, Science & Development

The latest milestone advances the company’s second clinical-stage therapeutic candidate and marks the first clinical programme built using its proprietary Au-HALO™ liver-targeting delivery technology and siRNA platform.

The survey will involve about 10,000 pregnant women across all 10 regions of Cameroon.

Amylyx developed the education initiative after researching the PBH patient community.

The clinical trial will assess SIL204, an investigational treatment developed by Silexion using small interfering RNA (siRNA) technology.

Moscow opened access to its MosMedAI platform to healthcare institutions across Russia in 2024, following a decree by Russian President Vladimir Putin.

The experimental vaccine was developed by scientists at the University of Oxford using the same vaccine technology employed in the Oxford-AstraZeneca COVID-19 vaccine.

Since South Sudan introduced SMC in 2022, the programme has helped protect children aged three to 59 months from malaria during peak transmission periods.

Researchers found that women who delivered prematurely consumed significantly lower amounts of protein, vitamins and essential minerals than those who carried their pregnancies to term.

This highly specific dependence could provide an opportunity for researchers to investigate new approaches to malaria treatment by targeting the parasite’s ability to obtain or use these fats.

NUR is designed to capture and interpret changes in the body’s surface temperature patterns, offering a new way to observe physiological signals associated with training and recovery.